Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Unilateral nerve deafness in childhood: a possible vascular etiology.
TPA causes divergent responses of Ca(2+)-dependent and Ca(2+)-independent isoforms of PKC in the nuclei of Caco-2 cells.
Impact of generic drug entry on cost-effectiveness analysis.
Principal Investigator
Chinese medicine GeGen-DanShen extract protects from myocardial ischemic injury through promoting angiogenesis via up-regulation of VEGF/VEGFR2 signaling pathway.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Davidson, Michael H.
One or more keywords matched the following items that are connected to
Davidson, Michael H.
Item Type
Name
Academic Article
Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
Academic Article
Emerging low-density lipoprotein therapies: Targeting PCSK9 for low-density lipoprotein reduction.
Academic Article
Diagnosis and treatment of familial hypercholesterolaemia.
Academic Article
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Academic Article
The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients.
Academic Article
Can We Cure Atherosclerosis?
Academic Article
PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.
Academic Article
Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.
Academic Article
Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
Concept
Proprotein Convertase 9
Academic Article
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial.
Search Criteria
Proprotein Convertase 1